Janet Hammond

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

AVIR

Current role

4 calls Latest call 2026-03-05

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Atea Pharmaceuticals, Inc. (AVIR)	MD, PhD Chief Development Officer	$590,892	—	$459,000	$437,440	$265,902	$14,000	$1,767,234
2024	Atea Pharmaceuticals, Inc. (AVIR)	MD, PhD Chief Development Officer	$573,682	—	$675,168	$689,855	$206,526	$13,800	$2,159,031
2023	Atea Pharmaceuticals, Inc. (AVIR)	MD, PhD Chief Development Officer	$556,973	—	$650,052	$667,772	$219,300	$13,200	$2,107,297
2022	Atea Pharmaceuticals, Inc. (AVIR)	MD, PhD Chief Development Officer	$530,450	—	$321,300	$973,693	$274,508	$12,200	$2,112,151
2021	Atea Pharmaceuticals, Inc. (AVIR)	M.D., Ph.D. Chief Development Officer	$515,000	—	—	$8,283,435	$196,988	$11,600	$9,007,023
2020	Atea Pharmaceuticals, Inc. (AVIR)	M.D., Ph.D. Chief Development Officer	$197,115	$431,203	—	$3,302,000	—	$100,000	$4,030,318

Earnings-call appearances and filed executive appointments or departures, newest first.